Live and On-Demand Activities

Filter Activities

Clear

Integrating the Latest Evidence into Practice: Expert Insights on Targeted Biologic Therapy for Pediatric and Adult Patients with Moderate to Severe Atopic Dermatitis

0.50 hr(s) | CME

Specialty: Atopic Dermatitis

Therapeutic Area(s): Dermatology

Release Date: October 20, 2021

Expiration Date: October 19, 2022

Location: Internet Activity Enduring

In this activity, an expert dermatologist discusses the latest evidence from the 30th European Academy of Dermatology and Venereology Congress for current and emerging targeted biologic therapies for moderate to severe atopic dermatitis in adults and children.

Advancing Treatment of von Willebrand Disease: A Visual Exploration on Personalizing Care with Current and Emerging Management Strategies

0.50 hr(s) | CME

Specialty: von Willebrand Disease

Therapeutic Area(s): Hematology, Malignant

Release Date: October 15, 2021

Expiration Date: October 14, 2022

Location: Internet Activity Enduring

In this activity, a hematology expert discusses the diagnostic assessment and management of von Willebrand disease, as well as available treatment options and strategies for shared decision-making.

Strategies To Improve Glucose Control with Mealtime Insulin

1.5 hr(s) | CME , CPE , NCPD

Specialty: Diabetes , Endocrinology

Therapeutic Area(s): Diabetes , Endocrinology , Family Medicine / Primary Care

Release Date: September 30, 2021

Expiration Date: March 31, 2023

Location:

This CME/NCPD/CPE activity includes five individual interactive, microlearning modules addressing care and outcomes for individuals with diabetes treated with mealtime insulin (MTI).  The modules incorporate case studies with embedded questions for an active learning experience. Learners can choose to participate in one or more of the modules to address their educational interests and needs based on their scope of practice and patient population.

Interprofessional Perspectives on Safety Management With Targeted Therapy for B-cell Malignancies

1.00 hr(s) | ABIM , CME , MOC , NCPD

Specialty: B-cell Malignancies

Therapeutic Area(s): Hematology, Malignant , Oncology

Release Date: October 4, 2021

Expiration Date: October 3, 2022

Location: Internet Activity Enduring

In this activity, a hematologist-oncologist, cardiologist, oncology nurse, and pharmacist team up to discuss targeted agents (including BTK and BCL-2 inhibitors) in B-cell malignancies and how the team works closely together to manage toxicity and safety concerns associated with targeted therapies. Case scenarios are presented to illustrate how a collaborative approach is not only necessary for managing patients with B-cell cancers, such as CLL and MCL, but can also improve patient outcomes through monitoring and managing adverse events.

Taking Action in Advanced Biliary Cancers: Expert Insights on Integrating Newly-Available and Innovative Therapeutics to Deliver Precision-Based Care

0.50 hr(s) | ABIM , CME , MOC , Royal College of Physicians and Surgeons of Canada

Specialty: Biliary Cancers

Therapeutic Area(s): Oncology

Release Date: September 28, 2021

Expiration Date: September 27, 2021

Location: Internet Activity Enduring

An expert discusses the latest data on targeted treatments for biliary cancers and integrating precision medicine with new and emerging strategies.

Ushering in A New Wave of Progress in Advanced Hepatobiliary Cancers: Expert Perspectives on Incorporating New Evidence and Innovative Therapeutics to Deliver Optimal, Patient-Centered Care

0.25 hr(s) | NCPD

Specialty: Hepatobiliary Cancers

Therapeutic Area(s): Oncology

Release Date: September 27, 2021

Expiration Date: September 26, 2022

Location: Internet Activity Enduring

After more than a decade of limited progress, the clinical management of advanced biliary tract cancers is rapidly changing. The introduction of new systemic therapies and the increased understanding of clinically actionable mutations in biliary tract cancers have led to the development of several biomarker-guided treatments and other promising strategies. In this activity, an oncology advanced practice provider discusses the latest clinical data regarding recently validated and forthcoming therapeutic strategies for patients with biliary tract cancers and the nurse’s role in improving patient outcomes through patient education, monitoring for and managing treatment-related toxicities, and counseling patients on therapeutic options, including clinical trial enrollment.

Across the Age Spectrum: Expert Insights on Emerging Uses of Targeted Therapy for the Treatment of Uncontrolled Moderate-to-Severe Asthma

0.50 hr(s) | CME

Specialty: Asthma

Therapeutic Area(s): Pulmonology

Release Date: September 27, 2021

Expiration Date: September 26, 2022

Location: Internet Activity Enduring

In this activity, an expert in pulmonology discusses the latest clinical research and treatment guidelines on approved biologic therapies for the management of adult and pediatric patients with uncontrolled moderate to severe asthma.

Secondary AML Through the Microscope: A Pathology-informed Guide to Modern Diagnostic and Treatment Principles

0.50 hr(s) | ABIM , ABPath , CC , CME , MOC

Specialty: AML

Therapeutic Area(s): Hematology, Malignant , Oncology

Release Date: September 20, 2021

Expiration Date: September 19, 2022

Location: Internet Activity Enduring

In this activity, an expert pathologist discusses secondary acute myeloid leukemia (AML) as well as the modern tools used in diagnostic assessment that can help facilitate appropriate risk stratification and collaborative treatment decisions so therapies beyond conventional chemotherapy options can be considered.

1 2 3 15
Copy link
Powered by Social Snap